
    
      The scarcity and the inadequacy of data make impossible the writing of evidence-based
      recommendations for prevention and management of infections in myelodysplastic syndrome.

      The aim of this study is to evaluate the incidence and the spectrum of the infections of MDS
      patients. Will be also evaluated potential risk factors.

      This study could help the definition of the optimal management of MDS patients in terms of
      prophylaxis of the infective complications and in terms of the correct administration of
      growth factors.
    
  